Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies

References

• Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev. 2011;35(5):901–911.
   PubMed Web of Science ®Google Scholar
• Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5:229–241.
   PubMedGoogle Scholar
• Högberg LD, Heddini A, Cars O. The global need for effective antibiotics: challenges and recent advances. Trends Pharmacol Sci. 2010;31(11):509–515.
   PubMed Web of Science ®Google Scholar
• Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007;13(12):1840–1846.
   PubMed Web of Science ®Google Scholar
• Hampton T. Report reveals scope of US antibiotic resistance threat. JAMA. 2013;310(16):1661–1663.
   PubMed Web of Science ®Google Scholar
• Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019;17:3.
   PubMedGoogle Scholar
• Humphreys G, Fleck F. United Nations meeting on antimicrobial resistance. WHO B World Health Organ. 2016;94(9):638–639.
   PubMed Web of Science ®Google Scholar
• Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66.
   PubMed Web of Science ®Google Scholar
• Interagency Coordination Group on Antimicrobial Resistance. No time to wait: securing the future from drug-resistant infections - report to the secretary-general of the united nations Apr 2019. Cited 2020 May 19. https://www.who.int/antimicrobial-resistance/interagency-coordination-group/en
   Google Scholar
• Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000–2005. Eur J Clin Pharmacol. 2007;63(12):1099–1106.
   PubMed Web of Science ®Google Scholar
• Luzzatto L, Hyry HI, Schieppati A, et al. Outrageous prices of orphan drugs: a call for collaboration. Lancet. 2018;392:791–794.
   PubMed Web of Science ®Google Scholar
• Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000;406(6797):775–781.
   PubMed Web of Science ®Google Scholar
• Dolgin E. Sequencing of superbugs seen as key to combating their spread. Nat Med. 2010;16(10):1054.
   Web of Science ®Google Scholar
• Dik J-WH, Vemer P, Friedrich AW, et al. Financial evaluations of antibiotic stewardship programs—a systematic review. Front Microbiol. 2015;6:317.
   PubMed Web of Science ®Google Scholar
• Parisi OI, Scrivano L, Sinicropi MS, et al. Polymeric nanoparticle constructs as devices for antibacterial therapy. Curr Opin Pharmacol. 2017;36:72–77.
   PubMed Web of Science ®Google Scholar
• Picca RA, Paladini F, Sportelli MC, et al. Combined approach for the development of efficient and safe nanoantimicrobials: the case of nanosilver-modified polyurethane foams. ACS Biomater Sci Eng. 2017;3(7):1417–1425.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wang W, Li C, et al. Reactive oxygen species–activatable liposomes regulating hypoxic tumor microenvironment for synergistic photo/chemodynamic therapies. Adv Funct Mater. 2019;29(44):1905013–1905023.
   Web of Science ®Google Scholar
• Liu C, Guo J, Yan X, et al. Antimicrobial nanomaterials against biofilms: an alternative strategy. Environ Rev. 2017;25:223–244.
   Google Scholar
• Busscher HJ, Van der Mei HC, Subbiahdoss G, et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med. 2012;4(153):153rv10.
   PubMed Web of Science ®Google Scholar
• Flemming H-C, Wingender J, Szewzyk U, et al. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14(9):563–575.
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–332.
   PubMed Web of Science ®Google Scholar
• Quan K, Zhang Z, Chen H, et al. Artificial channels in an infectious biofilm created by magnetic nanoparticles enhanced bacterial killing by antibiotics. Small. 2019;15(39):1902313–1902318.
   PubMed Web of Science ®Google Scholar
• de Beer D, Stoodley P, Lewandowski Z. Measurement of local diffusion coefficients in biofilms by microinjection and confocal microscopy. Biotechnol Bioeng. 1997;53(2):151–158.
   PubMed Web of Science ®Google Scholar
• Stewart PS. Mini-review: convection around biofilms. Biofouling. 2012;28:187–198.
   PubMed Web of Science ®Google Scholar
• Houry A, Gohar M, Deschamps J, et al. Bacterial swimmers that infiltrate and take over the biofilm matrix. Proc Natl Acad Sci USA. 2012;109(32):13088–13093.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Z, Xu C, et al. A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy. Biomaterials. 2019;197:284–293.
   PubMed Web of Science ®Google Scholar
• Romberg B, Hennink WE, Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res. 2008;25(1):55–71.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shi L, Su L, et al. Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control. Chem Soc Rev. 2019;48(2):428–446.
   PubMed Web of Science ®Google Scholar
• Li H, Huang J, Song Y, et al. Degradable carbon dots with broad-spectrum antibacterial activity. ACS Appl Mater Inter. 2018;10(32):26936–26946.
   PubMed Web of Science ®Google Scholar
• Zhao F, Gu W, Zhou J, et al. Solar-excited graphene quantum dots for bacterial inactivation via generation of reactive oxygen species. J Environ Sci Heal C. 2019;37(2):67–80.
   PubMed Web of Science ®Google Scholar
• Cai T, Fang G, Tian X, et al. Optimization of antibacterial efficacy of noble-metal-based core–shell nanostructures and effect of natural organic matter. ACS Nano. 2019;13(11):12694–12702.
   PubMed Web of Science ®Google Scholar
• Ge C, Wu R, Chong Y, et al. Synthesis of Pt hollow nanodendrites with enhanced peroxidase-like activity against bacterial infections: implication for wound healing. Adv Funct Mater. 2018;28(28):1801484–1801494.
   Web of Science ®Google Scholar
• Applerot G, Lipovsky A, Dror R, et al. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS‐mediated cell injury. Adv Funct Mater. 2009;19(6):842–852.
   Web of Science ®Google Scholar
• Gechev TS, Van Breusegem F, Stone JM, et al. Reactive oxygen species as signals that modulate plant stress responses and programmed cell death. Bioessays. 2006;28(11):1091–1101.
   PubMed Web of Science ®Google Scholar
• Thomas DD. Breathing new life into nitric oxide signaling: A brief overview of the interplay between oxygen and nitric oxide. Redox Biol. 2015;5:225–233.
   PubMed Web of Science ®Google Scholar
• Schapiro JM, Libby SJ, Fang FC. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc Natl Acad Sci USA. 2003;100:8496–8501.
   PubMed Web of Science ®Google Scholar
• Mihu MR, Cabral V, Pattabhi R, et al. Sustained nitric oxide-releasing nanoparticles interfere with methicillin-resistant Staphylococcus aureus adhesion and biofilm formation in a rat central venous catheter model. Antimicrob Agents Chemother. 2017;61(1):e02020–16.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang F, Ren J, et al. A series of MOF/Ce-based nanozymes with dual enzyme-like activity disrupting biofilms and hindering recolonization of bacteria. Biomaterials. 2019;208:21–31.
   PubMed Web of Science ®Google Scholar
• Flemming H-C, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–633.
   PubMed Web of Science ®Google Scholar
• Weldrick PJ, Hardman MJ, Paunov VN. Enhanced clearing of wound-related pathogenic bacterial biofilms using protease-functionalized antibiotic nanocarriers. ACS Appl Mater Inter. 2019;11(47):43902–43919.
   PubMed Web of Science ®Google Scholar
• Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev. 2005;57(10):1539–1550.
   PubMed Web of Science ®Google Scholar
• Gogokhia L, Buhrke K, Bell R, et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe. 2019;25(2):285–299.
   PubMed Web of Science ®Google Scholar
• Park J-H, von Maltzahn G, Ong LL, et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater. 2010;22(8):880–885.
   PubMed Web of Science ®Google Scholar
• Yan H, Teh C, Sreejith S, et al. Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery in vivo. Angew Chem Int Edit. 2012;51(33):8373–8377.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhou J, Zhuang J, et al. Strong near-infrared absorbing and biocompatible CuS nanoparticles for rapid and efficient photothermal ablation of gram-positive and-negative bacteria. ACS Appl Mater Inter. 2017;9(42):36606–36614.
   PubMed Web of Science ®Google Scholar
• Yu S, Li G, Liu R, et al. Dendritic Fe3O4@Poly(dopamine)@PAMAM nanocomposite as controllable NO-releasing material: a synergistic photothermal and NO antibacterial study. Adv Funct Mater. 2018;28(20):1707440–1707453.
   Web of Science ®Google Scholar
• Pihl M, Bruzell E, Andersson M. Bacterial biofilm elimination using gold nanorod localised surface plasmon resonance generated heat. Mater Sci Eng C. 2017;80:54–58.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Sahoo N, Sajanlal P, et al. Anomalous subsurface thermal behavior in tissue mimics upon near infrared irradiation mediated photothermal therapy. J Biomed Nanotechnol. 2014;10(3):405–414.
   PubMed Web of Science ®Google Scholar
• Quan K, Zhang Z, Ren Y, et al. Homogeneous distribution of magnetic, antimicrobial-carrying nanoparticles through an infectious biofilm enhances biofilm-killing efficacy. ACS Biomater Sci Eng. 2019;6(1):205–212.
   PubMed Web of Science ®Google Scholar
• Espinosa A, Di Corato R, Kolosnjaj-Tabi J, et al. Duality of iron oxide nanoparticles in cancer therapy: amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatment. ACS Nano. 2016;10(2):2436–2446.
   PubMed Web of Science ®Google Scholar
• Chen C, Wang S, Li L, et al. Bacterial magnetic nanoparticles for photothermal therapy of cancer under the guidance of MRI. Biomaterials. 2016;104:352–360.
   PubMed Web of Science ®Google Scholar
• Subbiahdoss G, Sharifi S, Grijpma DW, et al. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. Acta Biomater. 2012;8(6):2047–2055.
   PubMed Web of Science ®Google Scholar
• Geilich BM, Gelfat I, Sridhar S, et al. Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication. Biomaterials. 2017;119:78–85.
   PubMed Web of Science ®Google Scholar
• Wang X, Wu J, Li P, et al. Microenvironment-responsive magnetic nanocomposites based on silver nanoparticles/gentamicin for enhanced biofilm disruption by magnetic field. ACS Appl Mater Inter. 2018;10(41):34905–34915.
   PubMed Web of Science ®Google Scholar
• Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20(5):8856–8874.
   PubMed Web of Science ®Google Scholar
• Singh V, Kumar V, Kashyap S, et al. Graphene oxide synergistically enhances antibiotic efficacy in vancomycin-resistant Staphylococcus aureus. ACS Appl Bio Mater. 2019;2(3):1148–1157.
   PubMedGoogle Scholar
• Tu Y, Lv M, Xiu P, et al. Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. Nat Nanotechnol. 2013;8(8):594–601.
   PubMed Web of Science ®Google Scholar
• Huo S, Jiang Y, Gupta A, et al. Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure. ACS Nano. 2016;10(9):8732–8737.
   PubMed Web of Science ®Google Scholar
• Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13):1803–1815.
   PubMed Web of Science ®Google Scholar
• Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2(5):395–401.
   PubMed Web of Science ®Google Scholar
• Maan AA, Nazir A, Khan MKI, et al. The therapeutic properties and applications of Aloe vera: a review. J Herbs Med. 2018;12:1–10.
   Web of Science ®Google Scholar
• Ghafoor B, Ali MN, Ansari U, et al. New biofunctional loading of natural antimicrobial agent in biodegradable polymeric films for biomedical applications. Int J Biomater. 2016;2016:1–9.
   Web of Science ®Google Scholar
• Su Y, Zhao L, Meng F, et al. Triclosan loaded polyurethane micelles with pH and lipase sensitive properties for antibacterial applications and treatment of biofilms. Mater Sci Eng C. 2018;93:921–930.
   PubMed Web of Science ®Google Scholar
• Liu Y, Busscher HJ, Zhao B, et al. Surface-adaptive, antimicrobially loaded,micellar nanocarriers with enhanced penetration and killing efficiency in staphylococcal biofilms. ACS Nano. 2016;10(4):4779–4789.
   PubMed Web of Science ®Google Scholar
• Mi L, Jiang S. Integrated antimicrobial and nonfouling zwitterionic polymers. Angew Chem Int Edit. 2014;53(7):1746–1754.
   PubMed Web of Science ®Google Scholar
• Hu D, Li H, Wang B, et al. Surface-adaptive gold nanoparticles with effective adherence and enhanced photothermal ablation of methicillin-resistant Staphylococcus aureus biofilm. ACS Nano. 2017;11(9):9330–9339.
   PubMed Web of Science ®Google Scholar
• Xu HV, Zheng XT, Wang C, et al. Bioinspired antimicrobial nanodots with amphiphilic and zwitterionic-like characteristics for combating multidrug-resistant bacteria and biofilm removal. ACS Appl Nano Mater. 2018;1(5):2062–2068.
   Web of Science ®Google Scholar
• Liu X, Pang J, Xu F, et al. Simple approach to synthesize amino-functionalized carbon dots by carbonization of chitosan. Sci Rep. 2016;6(1):31100–31107.
   PubMedGoogle Scholar
• Dong Y, Shao J, Chen C, et al. Blue luminescent graphene quantum dots and graphene oxide prepared by tuning the carbonization degree of citric acid. Carbon. 2012;50(12):4738–4743.
   Web of Science ®Google Scholar
• Bagheri Z, Ehtesabi H, Rahmandoust M, et al. New insight into the concept of carbonization degree in synthesis of carbon dots to achieve facile smartphone based sensing platform. Sci Rep. 2017;7(1):11013–11023.
   PubMedGoogle Scholar
• Choi SK, Myc A, Silpe JE, et al. Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano. 2013;7(1):214–228.
   PubMed Web of Science ®Google Scholar
• Wrońska N, Felczak A, Zawadzka K, et al. Poly (propylene imine) dendrimers and amoxicillin as dual-action antibacterial agents. Molecules. 2015;20(10):19330–19342.
   PubMed Web of Science ®Google Scholar
• Dai T, Wang C, Wang Y, et al. A nanocomposite hydrogel with potent and broad-spectrum antibacterial activity. ACS Appl Mater Inter. 2018;10(17):15163–15173.
   PubMed Web of Science ®Google Scholar
• Lu Y, Slomberg DL, Shah A, et al. Nitric oxide-releasing amphiphilic poly (amidoamine)(PAMAM) dendrimers as antibacterial agents. Biomacromolecules. 2013;14(10):3589–3598.
   PubMed Web of Science ®Google Scholar
• Fux CA, Costerton JW, Stewart PS, et al. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13(1):34–40.
   PubMed Web of Science ®Google Scholar
• Van Leeuwenhoek A. Microscopical observations, about animals in the scurf of the teeth, the substance call’d worms in the nose, the cuticula consisting of scales. Philos Trans R Soc Lond. 1684;14:568–574.
   Google Scholar
• Wright GD. Q&A: antibiotic resistance: where does it come from and what can we do about it? BMC Biol. 2010;8(1):123.
   PubMedGoogle Scholar
• Whitchurch CB, Tolker-Nielsen T, Ragas PC, et al. Extracellular DNA required for bacterial biofilm formation. Science. 2002;295(5559):1487.
   PubMed Web of Science ®Google Scholar
• McDougald D, Rice SA, Barraud N, et al. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol. 2012;10(1):39–50.
   Web of Science ®Google Scholar
• Harapanahalli AK, Chen Y, Li J, et al. Influence of adhesion force on icaA and cidA gene expression and production of matrix components in Staphylococcus aureus biofilms. Appl Environ Microbiol. 2015;81(10):3369–3378.
   PubMed Web of Science ®Google Scholar
• Muszanska AK, Nejadnik MR, Chen Y, et al. Bacterial adhesion forces with substratum surfaces and the susceptibility of biofilms to antibiotics. Antimicrob Agents Chemother. 2012;56(9):4961–4964.
   PubMed Web of Science ®Google Scholar
• Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother. 2004;48(7):2659–2664.
   PubMed Web of Science ®Google Scholar
• Boles BR, Horswill AR. Staphylococcal biofilm disassembly. Trends Microbiol. 2011;19(9):449–455.
   PubMed Web of Science ®Google Scholar
• Wood TK, Knabel SJ, Kwan BW. Bacterial persister cell formation and dormancy. Appl Environ Microbiol. 2013;79(23):7116–7121.
   PubMed Web of Science ®Google Scholar
• El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015;28(1):191–207.
   PubMed Web of Science ®Google Scholar
• Nicoloff H, Hjort K, Levin BR, et al. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat Microbiol. 2019;4(3):504–514.
   PubMed Web of Science ®Google Scholar
• Nesse LL, Simm R. A hotspot for emerging bacterial genotypes. Adv App Microbiol. 2018;103:223–246.
   PubMed Web of Science ®Google Scholar
• Sun D. Pull in and push out: mechanisms of horizontal gene transfer in bacteria. Front Microbiol. 2018;9:2154–2161.
   PubMed Web of Science ®Google Scholar
• Hengzhuang W, Wu H, Ciofu O, et al. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2011;55(9):4469–4474.
   PubMed Web of Science ®Google Scholar
• Hengzhuang W, Wu H, Ciofu O, et al. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother. 2012;56(5):2683–2690.
   PubMed Web of Science ®Google Scholar
• Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Update. 2010;13(6):151–171.
   PubMed Web of Science ®Google Scholar
• Criswell D The “evolution” of antibiotic resistance.” Institute for creation research. Web 28. Oct 2014. 2004.
   Google Scholar
• Blair JMA, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51.
   PubMed Web of Science ®Google Scholar
• Ma Y-X, Wang C-Y, Li -Y-Y, et al. Considerations and caveats in combating ESKAPE pathogens against nosocomial Infections. Adv Sci. 2020;7(1):1901872–1901914.
   Web of Science ®Google Scholar
• Markley JL, Fang L, Gasparrini AJ, et al. Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes. ACS Infect Dis. 2019;5(4):618–633.
   PubMed Web of Science ®Google Scholar
• Li F, Collins JG, Keene FR. Ruthenium complexes as antimicrobial agents. Chem Soc Rev. 2015;44(8):2529–2542.
   PubMed Web of Science ®Google Scholar
• Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033–18056.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Laxminarayan R, Mendelson M. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Int J Infect Dis. 2017;54:77–84.
   PubMed Web of Science ®Google Scholar
• Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 2002;99(11):7687–7692.
   PubMed Web of Science ®Google Scholar
• Fabbretti A, Çapuni R, Giuliodori AM, et al. Characterization of the self-resistance mechanism to dityromycin in the Streptomyces producer strain. mSphere. 2019;4(5):e00554–19.
   PubMed Web of Science ®Google Scholar
• Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315(5819):1709–1712.
   PubMed Web of Science ®Google Scholar
• Barrangou R. The roles of CRISPR–Cas systems in adaptive immunity and beyond. Curr Opin Immunol. 2015;32:36–41.
   PubMed Web of Science ®Google Scholar
• Fuda CC, Fisher JF, Mobashery S. Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci. 2005;62:2617–2633.
   PubMed Web of Science ®Google Scholar
• Wang K, Nicholaou M. Suppression of antimicrobial resistance in MRSA using CRISPR-dCas9. Clin Lab Sci. 2017;30(4):207–213.
   Google Scholar
• Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science. 2010;327(5962):167–170.
   PubMed Web of Science ®Google Scholar
• Weissman JL, Laljani RM, Fagan WF, et al. Visualization and prediction of CRISPR incidence in microbial trait-space to identify drivers of antiviral immune strategy. ISME. 2019;13(10):2589–2602.
   PubMed Web of Science ®Google Scholar
• Koebnik R, Locher KP, Van Gelder P. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol. 2000;37(2):239–253.
   PubMed Web of Science ®Google Scholar
• Masuda N, Sakagawa E, Ohya S, et al. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44(12):3322–3327.
   PubMed Web of Science ®Google Scholar
• Ferrer-Espada R, Shahrour H, Pitts B, et al. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains. Sci Rep. 2019;9(1):3452–3463.
   PubMedGoogle Scholar
• Piddock LJV. Multidrug-resistance efflux pumps? Not just for resistance. Nat Rev Microbiol. 2006;4(8):629–636.
   PubMed Web of Science ®Google Scholar
• Putman M, van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev. 2000;64(4):672–693.
   PubMed Web of Science ®Google Scholar
• Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med. 2007;39(3):162–176.
   PubMed Web of Science ®Google Scholar
• Blanco P, Hernando-Amado S, Reales-Calderon JA, et al. Bacterial multidrug efflux pumps: much more than antibiotic resistance determinants. Microorganisms. 2016;4(1):14–27.
   PubMed Web of Science ®Google Scholar
• Blake KL, Randall CP, Neill AJ. In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance. Antimicrob Agents Chemother. 2011;55(5):2362–2368.
   PubMed Web of Science ®Google Scholar
• Carniello V, Harapanahalli AK, Busscher HJ, et al. Adhesion force sensing and activation of a membrane-bound sensor to activate nisin efflux pumps in Staphylococcus aureus under mechanical and chemical stresses. J Colloid Interf Sci. 2018;512:14–20.
   PubMed Web of Science ®Google Scholar
• Abed N, Couvreur P. Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents. 2014;43(6):485–496.
   PubMed Web of Science ®Google Scholar
• Ahmad Nor Y, Niu Y, Karmakar S, et al. Shaping nanoparticles with hydrophilic compositions and hydrophobic properties as nanocarriers for antibiotic delivery. ACS Central Sci. 2015;1(6):328–334.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ren Y, Li Y, et al. Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models. Acta Biomater. 2018;79:331–343.
   PubMed Web of Science ®Google Scholar
• Ejim L, Farha MA, Falconer SB, et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol. 2011;7(6):348–350.
   PubMed Web of Science ®Google Scholar
• Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis. 2005;9(3):127–138.
   PubMed Web of Science ®Google Scholar
• Brooks BD, Brooks AE. Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev. 2014;78:14–27.
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Phan J, Schairer DO, et al. Antimicrobial and anti-Inflammatory activity of chitosan–alginate nanoparticles: A targeted therapy for cutaneous pathogens. J Invest Dermatol. 2013;133(5):1231–1239.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48.
   PubMed Web of Science ®Google Scholar
• Beppler C, Tekin E, White C, et al. When more is less: emergent suppressive interactions in three-drug combinations. BMC Microbiol. 2017;17(1):107–115.
   PubMedGoogle Scholar
• Neut D, Hendriks JGE, van Horn JR, et al. Antimicrobial efficacy of gentamicin-loaded acrylic bone cements with fusidic acid or clindamycin added. J Orthop Res. 2006;24(2):291–299.
   PubMed Web of Science ®Google Scholar
• Dey R, De K, Mukherjee R, et al. Small antibacterial molecules highly active against drug-resistant Staphylococcus aureus. MedChemComm. 2019;10(11):1907–1915.
   PubMed Web of Science ®Google Scholar
• Mwangi J, Yin Y, Wang G, et al. The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection. Proc Natl Acad Sci USA. 2019;116(52):26516–26522.
   Web of Science ®Google Scholar
• Armengol E, Domenech O, Fusté E, et al. Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery. Infect Drug Resist. 2019;12:2031–2038.
   PubMed Web of Science ®Google Scholar
• Wu D-Q, Zhu J, Han H, et al. Synthesis and characterization of arginine-NIPAAm hybrid hydrogel as wound dressing: in vitro and in vivo study. Acta Biomater. 2018;65:305–316.
   PubMed Web of Science ®Google Scholar
• Onesti M, Carella S, Scuderi N. Effectiveness of antimicrobial-coated sutures for the prevention of surgical site infection: a review of the literature. Eur Rev Med Pharmacol Sci. 2018;22:5729–5739.
   PubMed Web of Science ®Google Scholar
• Ruden S, Rieder A, Schwartz T, et al. Synergy pattern of short cationic antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa. Front Microbiol. 2019;10:2740.
   PubMedGoogle Scholar
• Maiden MM, Hunt AMA, Zachos MP, et al. Triclosan is an aminoglycoside adjuvant for eradication of Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2018;62(6):e00146–18.
   PubMed Web of Science ®Google Scholar
• Westfall C, Flores-Mireles AL, Robinson JI, et al. The widely used antimicrobial triclosan induces high levels of antibiotic tolerance in vitro and reduces antibiotic efficacy up to 100-fold in vivo. Antimicrob Agents Chemother. 2019;63(5):e02312–18.
   PubMed Web of Science ®Google Scholar
• Khan R, Islam B, Akram M, et al. Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. 2009;14(2):586–597.
   PubMed Web of Science ®Google Scholar
• Solórzano-Santos F, Miranda-Novales MG. Essential oils from aromatic herbs as antimicrobial agents. Curr Opin Biotech. 2012;23(2):136–141.
   PubMed Web of Science ®Google Scholar
• Palaniappan K, Holley RA. Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria. Int J Food Microbiol. 2010;140(2):164–168.
   PubMed Web of Science ®Google Scholar
• Aburjai T, Darwish RM, Al-Khalil S, et al. Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Pseudomonas aeruginosa. J Ethnopharmacol. 2001;76(1):39–44.
   PubMed Web of Science ®Google Scholar
• Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 2008;15(8):639–652.
   PubMed Web of Science ®Google Scholar
• Carpenter AW, Slomberg DL, Rao KS, et al. Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. ACS Nano. 2011;5(9):7235–7244.
   PubMed Web of Science ®Google Scholar
• Nye R, Robinia K, Peterson P, et al. Efficacy of a nitric oxide dressing in decreasing bacterial counts on human skin. J Wound Care. 2018;27(Sup7):S19–S25.
   PubMedGoogle Scholar
• Dizaj SM, Lotfipur F, Barzegar-Jalali M, et al. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C. 2014;44(1):278–284.
   PubMedGoogle Scholar
• Le Ouay B, Stellacci F. Antibacterial activity of silver nanoparticles: A surface science insight. Nano Today. 2015;10(3):339–354.
   Web of Science ®Google Scholar
• Huh AJ, Kwon YJ. “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128–145.
   PubMed Web of Science ®Google Scholar
• Egorov A, Rubtsova M, Grigorenko V, et al. The role of the Ω-loop in regulation of the catalytic activity of TEM-type β-lactamases. Biomolecules. 2019;9(12):854–869.
   PubMed Web of Science ®Google Scholar
• Tooke CL, Hinchliffe P, Bragginton EC, et al. β-Lactamases and β-lactamase inhibitors in the 21st century. J Mol Biol. 2019;431(18):3472–3500.
   PubMed Web of Science ®Google Scholar
• Duan F, Feng X, Jin Y, et al. Metal–carbenicillin framework-based nanoantibiotics with enhanced penetration and highly efficient inhibition of MRSA. Biomaterials. 2017;144:155–165.
   PubMed Web of Science ®Google Scholar
• Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis. 2001;33(Supplement_3):S147–S156.
   PubMedGoogle Scholar
• Hong J, Hu J, Ke F. Experimental induction of bacterial resistance to the antimicrobial peptide tachyplesin I and investigation of the resistance mechanisms. Antimicrob Agents Chemother. 2016;60(10):6067–6075.
   PubMed Web of Science ®Google Scholar
• Pope CF, Sullivan DM, McHugh TD, et al. A practical guide to measuring mutation rates in antibiotic resistance. Antimicrob Agents Chemother. 2008;52(4):1209–1214.
   PubMed Web of Science ®Google Scholar
• Drlica K, Zhao X. Mutant selection window hypothesis updated. Clin Infect Dis. 2007;44(5):681–688.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhao X, Domagala J, et al. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43(7):1756–1758.
   PubMed Web of Science ®Google Scholar
• Cirz RT, Romesberg FE. Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob Agents Chemother. 2006;50(1):220–225.
   PubMed Web of Science ®Google Scholar
• Sen SK, Mohapatra SK, Satpathy S, et al. Characterization of hot water spring source isolated clones of bacteria and their industrial applicability. Int J Chem Res. 2010;2(1):01–07.
   Google Scholar
• Gleeson D, O’Connell A, Jordan K. Review of potential sources and control of thermoduric bacteria in bulk-tank milk. Irish J Agr Food Res. 2013;52(2):217–227.
   Web of Science ®Google Scholar
• Vatansever F, de Melo WC, Avci P, et al. Antimicrobial strategies centered around reactive oxygen species–bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev. 2013;37(6):955–989.
   PubMed Web of Science ®Google Scholar
• Panáček A, Kvítek L, Smékalová M, et al. Bacterial resistance to silver nanoparticles and how to overcome it. Nat Nanotech. 2018;13(1):65–71.
   PubMed Web of Science ®Google Scholar
• Xie Y, Liu Y, Yang J, et al. Gold nanoclusters for targeting methicillin-resistant Staphylococcus aureus in vivo. Angew Chem Int Edit. 2018;57(15):3958–3962.
   PubMed Web of Science ®Google Scholar
• Zhen J-B, Kang P-W, Zhao M-H, et al. Silver nanoparticle conjugated star PCL-b-AMPs copolymer as nanocomposite exhibits efficient antibacterial properties. Bioconjugate Chem. 2020;31(1):51–63.
   PubMed Web of Science ®Google Scholar
• Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019;17:479–496.
   PubMed Web of Science ®Google Scholar
• Silva RF, Mendonça SC, Carvalho LM, et al. Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLoS Gent. 2011;7(7):e1002181.
   PubMed Web of Science ®Google Scholar
• Purcell A. Superbugs may be here to stay. NewScientist. 2011 August;2824:6.
   Google Scholar
• Getino M, Sanabria-Ríos DJ, Fernández-López R, et al. Synthetic fatty acids prevent plasmid-mediated horizontal gene transfer. mBio. 2015;6(5):e01032–15.
   PubMed Web of Science ®Google Scholar
• Moriarty T, Grainger D, Richards R. Challenges in linking preclinical anti-microbial research strategies with clinical outcomes for device-associated infections. Eur Cell Mater. 2014;28:112–128.
   PubMed Web of Science ®Google Scholar
• Campoccia D, Montanaro L, Moriarty T, et al. The selection of appropriate bacterial strains in preclinical evaluation of infection-resistant biomaterials. Int J Artif Organs. 2008;31(9):841–847.
   PubMed Web of Science ®Google Scholar
• Busscher HJ, Woudstra W, van Kooten TG, et al. Accepting higher morbidity in exchange for sacrificing fewer animals in studies developing novel infection-control strategies. Biomaterials. 2020;232:119737–119744.
   PubMed Web of Science ®Google Scholar